Figure 1.
Figure 1. Use and indications for reduced-intensity conditioning regimens as reported to the Center for International Blood and Marrow Research (CIBMTR) . / Abbreviations: ALL, acute lymphocytic leukemia; AML, acute myeloid leukemia; CLL, chronic lymphocytic leukemia; CML, chronic myeloid leukemia; HD, Hodgkin disease; MCL, mantle cell leukemia; MDS, myelodysplastic syndromes; MM, multiple myeloma; MPS, myeloproliferative syndromes; NHL, non-Hodgkin lymphoma; NRM, non-relapse mortality; OS, overall survival; SAA, severe aplastic anemia; TBI, total-body irradiation.

Use and indications for reduced-intensity conditioning regimens as reported to the Center for International Blood and Marrow Research (CIBMTR)

Abbreviations: ALL, acute lymphocytic leukemia; AML, acute myeloid leukemia; CLL, chronic lymphocytic leukemia; CML, chronic myeloid leukemia; HD, Hodgkin disease; MCL, mantle cell leukemia; MDS, myelodysplastic syndromes; MM, multiple myeloma; MPS, myeloproliferative syndromes; NHL, non-Hodgkin lymphoma; NRM, non-relapse mortality; OS, overall survival; SAA, severe aplastic anemia; TBI, total-body irradiation.

Close Modal

or Create an Account

Close Modal
Close Modal